Gainesville, FL, United States of America

Lawrence Flowers

This inventor holds 1 USPTO granted patent. Top assignee: University of Florida Research Foundation Inc.. Active years: 2007.


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2007

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Lawrence Flowers

Introduction

Lawrence Flowers is an accomplished inventor based in Gainesville, FL (US). He has made significant contributions to the field of biochemistry, particularly in the area of protein kinases. His work focuses on developing innovative solutions for treating inflammatory and oncological disorders.

Latest Patents

Lawrence Flowers holds a patent for "Inhibitors of autophosphorylation protein kinases." This invention concerns peptide molecules that specifically inhibit the enzymatic function of tyrosine kinases, including the JAK and EGF receptor (EGFR) family of kinases. The patent addresses the critical process of phosphorylation, which is essential for signal transduction among proteins in a cell. By inhibiting tyrosine kinase autophosphorylation activities, the invention aims to shut down the signaling pathways that can lead to uncontrolled activation in inflammatory disorders and cancer. The application also includes antibodies that bind to a tyrosine kinase autophosphorylation site, along with pharmaceutically acceptable formulations for treating these conditions.

Career Highlights

Lawrence Flowers is affiliated with the University of Florida Research Foundation Inc., where he continues to advance his research and innovations. His work has the potential to impact the treatment of various diseases significantly.

Collaborations

Lawrence has collaborated with notable colleagues, including Howard Marcellus Johnson and Mustafa G Mujtaba, to further enhance his research efforts.

Conclusion

Lawrence Flowers exemplifies the spirit of innovation in the field of biochemistry. His patent on inhibitors of autophosphorylation protein kinases showcases his commitment to developing solutions for critical health issues.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…